Huron Consulting Group Inc.
NASDAQ•HURN
執行長: Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A.
板塊: Industrials
行業: Consulting Services
上市日期: 2004-10-13
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment provides digital solutions, spanning technology, and analytic-related services; Huron Research product suite, a software suite designed to facilitate and enhance research administration service delivery and compliance; research-focused consulting and managed services; strategy and operations consulting services for public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment delivers digital services and software products, and financial advisory services to financial, energy and utilities, professional and business services, life science, consumer products, and industrials and manufacturing industries, as well as public sector and nonprofit organizations. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
聯絡資訊
550 West Van Buren Street, Chicago, IL, 60607, United States
312-583-8700
市值
$2.21B
本益比 (TTM)
21.5
27.6
股息率
--
52周最高
$186.78
52周最低
$116.12
52周範圍
排名29Top 17.8%
5.2
F-Score
改良版 Piotroski 分析
基於 10 年期基本面
一般 • 5.2 / 9 分
評分區間 (0-9)
8-9: 價值優異
6-7: 基本面強勁
4-5: 整體穩健
0-3: 表現疲弱
資料區間: 2016-2025
財務儀表板
Q4 2025 數據
營業收入
$441.96M+0.00%
近4季度走勢
每股收益
$1.77+0.00%
近4季度走勢
自由現金流
$123.83M+0.00%
近4季度走勢
2025 Annual 財報亮點
核心亮點
Revenue Growth Across Segments Revenues before reimbursable expenses increased 11.9% to $1.66B in 2025, driven by Consulting/Managed Services strength across all segments.
Adjusted EBITDA Margin Rises Adjusted EBITDA margin rose to 14.3% in 2025, up from 13.5% last year, showing operational leverage gains despite net income dip.
Capital Returned to Shareholders Deployed $166.2M capital returning value to shareholders through common stock repurchases during 2025, with $99.0M remaining authorization.
Healthcare Revenue Strength Healthcare segment revenues grew 10.7% to $837.5M before reimbursements, supported by strong consulting demand across providers.
關注風險
Talent Retention Competitive Risk Inability to hire and retain skilled professionals in competitive labor market risks increasing labor costs and negatively affecting margins.
Short-Term Client Contract Risk Short-term client contracts, often 12 months or less, create unpredictable operating results and revenue volume fluctuations year-to-year.
Investment Impairment Potential Convertible debt investment impairment risk exists due to external regulatory environment impacting investee cash flows and profitability, noted by $10.4M charge in 2025.
Managing Global Growth Challenges Managing organizational challenges associated with continued global growth risks impairing ability to maintain standards and execute strategy effectively.
未來展望
Strategy Focus on Digital Growth Growth strategy emphasizes accelerating Healthcare/Education expansion while rapidly growing global digital capability leveraging AI evolution across industries.
Commitment to Margin Expansion Committed to achieving operating income margin expansion by improving pricing realization and focusing on high-return business areas.
Financing Flexibility Maintained Internally generated liquidity plus $578.6M unused credit capacity supports long-term growth needs, acquisitions, and capital expenditures.
Continued Strategic Acquisitions Company plans to continue executing strategic, tuck-in acquisitions to bolster capabilities across key industry segments like Healthcare and Commercial.
同行對比
營業收入 (TTM)
$8.87B
$5.42B
$5.38B
毛利率 (最新季度)
48.0%
42.0%
39.7%
關鍵指標
股票代碼 | 市值 | 本益比 (TTM) | 股東權益報酬率 (TTM) | 負債率 |
|---|---|---|---|---|
| FTAI | $24.89B | 49.7 | 257.0% | 78.9% |
| UNF | $4.68B | 44.1 | 4.7% | 2.9% |
| TEX | $3.85B | 17.4 | 11.2% | 45.8% |
長期趨勢
近4季度
營業收入
淨利
營運現金流
4季度營業收入複合增長率
3.8%
溫和增長
4季度淨利複合增長率
7.7%
盈利能力逐步提升
現金流穩定性
75%
現金流波動較大
深度研究
下次財報:2026年4月27日
每股收益:-
|營業收入:-
財務數據
電話會議
財務報告
新聞
損益表
資產負債表
現金流量表
財務比率
變化率
損益表 | 過去12個月 |
|---|
無資料